Aortic Disease Clinical Trials
The aortic clinical trials team is interested in seeing how exciting new aortic devices and drugs can help to improve the outcomes and quality of life for those living with aortic diseases.
Feel free to call or e-mail the Knight Cardiovascular Institute research team at 503-418-1964 or by emailing firstname.lastname@example.org. You will then be forwarded to the appropriate research team member who will be able to see if you qualify for any of the clinical trials being offered at OHSU.
You can also find all the of heart failure clinical trials, that are currently enrolling patients, below.
Clinical Trial Name
|Fibrillin Surveillance: Use of Plasma-detected Fibrillin Peptide Fragments for pre- and Post-operative Aortic Aneurysm and Dissection Surveillance||Cherrie Abraham, MD FRCSC|| Lynn Sakai, PhD / Amir-Farzin Azarbal, MD / Gregory Landry, MD / Enjae Jung, MD / Khanh Nguyen, MD||IRB00016252|
|GORE TBE: Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracis Aorta||Cherrie Abraham, MD FRCSC||Gregory Landry, MD / Amir-Farzin Azarbal, MD / Jaishankar Raman, MBBS, MMed, PhD, FRACS / Enjae Jung, MD / Ryan Schenning, MD / Khanh Nguyen, MD||IRB00016197|
|Zenith p-Branch Study: Zenith® p-Branch® Endovascular Graft Pivotal Study||Cherrie Abraham, MD FRCSC||Gregory Landry, MD / Timothy Liem, MD, MBA, FACS||IRB00015370|